You are here

Article metrics

Article menu

Download PDFPDF

Research Article
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019110
Jan 2020552
Feb 2020771
Mar 202030307
Apr 202025257
May 2020313114
Jun 202017174
Jul 202017173
Aug 2020885
Sep 202029296
Oct 202031319
Nov 202012124
Dec 202039394
Jan 202125255
Feb 202121217
Mar 202134349
Apr 2021303014
May 202121214
Jun 202129293
Jul 202130309
Aug 2021313112
Sep 2021323212
Oct 202137378
Nov 202132327
Dec 202143437
Jan 202244475
Feb 202245486
Mar 2022606114
Apr 2022697012
May 2022869116
Jun 202258605
Jul 202249535
Aug 202265665
Sep 2022656517
Oct 202237383
Nov 2022616414
Dec 202228280
Jan 202352528
Feb 202355564
Mar 202360639
Apr 2023383916
May 2023383810
Jun 202335366
Jul 2023333315
Aug 202361619
Sep 202380806
Oct 202317217211
Nov 20232382399
Dec 202320620611
Jan 2024888936
Feb 2024727210
Mar 2024717129
Apr 2024373713
May 2024454516
Jun 2024595814
Jul 2024545513
Aug 2024272810
Sep 2024373716
Oct 2024434313
Nov 202412312616
Dec 2024464912
Jan 2025787826
Feb 2025414117
Mar 2025848426
Apr 2025505119
May 2025495019
Jun 2025474713
Sep 2025110
Total34043445697